Want to see CNC full AI Analyst Report?
CNC Stock Chart & Stats
$65.00
$0.16(0.25%)
At close: 4:00 PM EDT
$65.00
$0.16(0.25%)
Day’s Range― - ―
52-Week Range$28.24 - $69.36
Previous CloseN/A
Volume986.83K
Average Volume (3M)4.74M
Market Cap
$32.22B
Enterprise Value$48.14K
Total Cash (Recent Filing)$27.06B
Total Debt (Recent Filing)$16.11B
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Oct 27, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.40
Shares Outstanding493,995,000
10 Day Avg. Volume4,026,327
30 Day Avg. Volume4,738,535
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.01
Price to Sales (P/S)0.10
P/FCF Ratio4.68
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$72.50Price Target Upside11.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)4.8
Revenue Forecast (FY)$195.92B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationRobust operating and free cash flow provides funding for claims, investment, debt reduction and other obligations even during reported losses. This supports financial resilience, although the pack notes that cash generation has been volatile across prior years.
Margin Recovery And Higher Earnings OutlookImproved health benefit ratios, better Medicaid rates and stronger Marketplace and PDP margins indicate active earnings recovery across major businesses. The raised outlook suggests management has identified durable operational levers, though execution remains important.
Improving Leverage And Debt ManagementLower leverage and active debt reduction improve financial flexibility and reduce exposure to refinancing and interest burdens. Combined with sizable equity and strong current cash flow, the balance sheet can better absorb medical-cost or regulatory volatility.
Bears Say
Recent Profitability CollapseThe recent swing to operating and net losses weakens retained capital, shareholder returns and confidence in earnings quality. Although the pack describes the deterioration as recent rather than structural, restoring sustainable margins remains essential for the fundamental case.
Medicaid Membership Attrition And Acuity RiskFewer Medicaid members reduce scale and premium volume, while higher acuity can increase claims costs and pressure health benefit ratios. These effects may persist through eligibility redeterminations and enrollment changes, challenging margin restoration and contract economics.
Medical-Cost And Regulatory UncertaintyPersistent specialty-drug and care-category inflation can offset pricing and productivity gains. Regulatory changes involving program integrity, eligibility and quality methodologies may also alter enrollment, acuity and reimbursement, making claims costs and revenue less predictable.
Centene News
CNC FAQ
What was Centene’s price range in the past 12 months?
Centene lowest stock price was $28.24 and its highest was $69.36 in the past 12 months.
What is Centene’s market cap?
Centene’s market cap is $32.22B.
When is Centene’s upcoming earnings report date?
Centene’s upcoming earnings report date is Oct 27, 2026 which is in 53 days.
How were Centene’s earnings last quarter?
Centene released its earnings results on Jul 28, 2026. The company reported $2.51 earnings per share for the quarter, beating the consensus estimate of $1.085 by $1.425.
Is Centene overvalued?
According to Wall Street analysts Centene’s price is currently Undervalued.
Does Centene pay dividends?
Centene does not currently pay dividends.
What is Centene’s EPS estimate?
Centene’s EPS estimate is 0.1.
How many shares outstanding does Centene have?
Centene has 493,995,000 shares outstanding.
What happened to Centene’s price movement after its last earnings report?
Centene reported an EPS of $2.51 in its last earnings report, beating expectations of $1.085. Following the earnings report the stock price went down -0.265%.
Which hedge fund is a major shareholder of Centene?
Currently, no hedge funds are holding shares in CNC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Centene Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$72.50 (11.54% Upside)
$72.50 (11.54% Upside)
Blogger Sentiment
Bullish
CNC Sentiment 87%
Sector Average 60%
Sector Average 60%
Hedge Fund Trend
Decreased
By 3.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $12.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 5.4%
Last 30 Days ▲ 5.4%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
127.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-3.92%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Centene
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
CNC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid financial momentum and tangible operational progress: a Q2 EPS beat, raised full-year EPS guidance, margin improvements in Marketplace and PDP, better-than-expected state rate development for Medicaid, strong cash flow and balance-sheet improvements, and measurable cost-management wins (including AI-enabled initiatives). However, the company faces meaningful near-term headwinds: membership attrition (especially in Medicaid expansion), acuity shifts that could pressure medical cost ratios, regulatory/program uncertainty (OB3, STARS, eligibility verification), and a portion of Q2 upside tied to nonrecurring prior-period settlements. On balance, the positive guidance revisions, margin recoveries in key segments, cash and debt improvement, and demonstrated operating discipline outweigh the near-term risks flagged by management.View all CNC earnings summariesCNC Revenue Breakdown
88.08% Premium
1.55% Service
10.37% Premium tax
CNC Stock 12 Month Forecast
Average Price Target
$72.50
▲(11.54% Upside)
Technical Analysis
Ownership Overview
0.74% Insiders
22.18% Mutual Funds
18.55% Other Institutional Investors
28.00% Public Companies and Individual Investors